Your browser doesn't support javascript.
loading
The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD.
Viggiano, Pasquale; Miere, Alexandra; Borrelli, Enrico; Boscia, Giacomo; Grassi, Maria Oliva; Souied, Eric H; Alessio, Giovanni; Boscia, Francesco.
Afiliação
  • Viggiano P; Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro," Bari, Italy.
  • Miere A; Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris Est, Créteil, France.
  • Borrelli E; Ophthalmology Department, San Raffaele University Hospital, Milan, Italy.
  • Boscia G; Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro," Bari, Italy.
  • Grassi MO; Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro," Bari, Italy.
  • Souied EH; Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris Est, Créteil, France.
  • Alessio G; Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro," Bari, Italy.
  • Boscia F; Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro," Bari, Italy.
Invest Ophthalmol Vis Sci ; 64(14): 32, 2023 Nov 01.
Article em En | MEDLINE | ID: mdl-37988106
ABSTRACT

Purpose:

To investigate the impact of diabetic retinopathy (DR) on morphological choriocapillaris (CC) modifications in eyes with type 1 macular neovascularization (MNV) secondary to AMD using optical coherence tomography angiography (OCTA).

Methods:

Eyes with AMD-related type 1 MNV with and without DR were prospectively included. We performed 3 × 3 mm OCTA scans at two visits before the loading phase of intravitreal injections of aflibercept (T1) and 1 month after the last injection (T2). OCTA En face flow images of the CC were analyzed for flow deficit percentage (FD%), FD average area and FD number in a 500-µm-wide ring surrounding the dark halo (DH) around type 1 MNV.

Results:

A total of 65 eyes, out of which 30 eyes had mild DR, were included. In the group without diabetes, there was a gradual reduction in FD% in the CC ring around the DH after antiangiogenic therapy, indicating reperfusion of the CC (P = 0.003). However, in the DR group, there were no significant changes in CC parameters between the two study visits. Specifically, the FD% in the CC ring around the DH did not show a significant reduction at T2 compared with T1 values (P > 0.05). Furthermore, the comparison of the variation in FD% between the two groups was statistically significant. The nondiabetic group exhibited a gradual CC reperfusion after the loading phase of aflibercept, whereas the diabetic eyes did not show significant changes (P = 0.029).

Conclusions:

The CC surrounding the DH associated to type 1 MNV exhibited greater hypoperfusion in diabetic eyes compared with eyes without diabetes, both before starting therapy and after the loading phase. Hence, DR may be a potential risk factor in the development and progression of late-stage AMD and may also influence the response to antiangiogenic therapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Retinopatia Diabética / Degeneração Macular Exsudativa Limite: Humans Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Retinopatia Diabética / Degeneração Macular Exsudativa Limite: Humans Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália